Work

Addressing the Opioid Epidemic — Opportunities in the Postmarketing Setting

Year: 2017

Type: article

Abstract: The Food and Drug Administration has proposed allowing public health considerations to be factored into drug-approval decisions for opioids. It may already be possible, however, for the agency to use labeling changes to affect marketing and promotion.

Source: New England Journal of Medicine

DOI: 10.1056/nejmp1614972

Authors: Bruce M. Psaty, Joseph O. Merrill

Institutions: Kaiser Permanente Washington Health Research Institute, University of Washington

Language: English

Topic: Opioid Use Disorder Treatment

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2606026740

FWCI: 4.616

Cites: 5

Cited by: 23

Related to: 10